Tiragolumab
Product Specifications
CAS Number
1918185-84-8
Target
Immunology/Inflammation related, Others
Related Pathways
Immunology/Inflammation, Others
Purity
0.988
Bioactivity
Tiragolumab (MTIG-7192A) is a monoclonal antibody that targets T-cell immunoglobulin and the ITIM structural domain (TIGIT) .Tiragolumab is often used in combination with the PD-L1 inhibitor, Atezolizumab, for the treatment of solid malignant tumors such as non-small cell lung cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog